Stylus Medicine is developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics. The company’s approach is versatile and modular, with potential therapeutic application across oncology, autoimmune, genetic diseases, and beyond.
Company Details
- Employees
- 39
- Address
- One Kendall Square,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.stylusmedicine.com/
- HQ
- Cambridge, Massachusetts
Stylus Medicine Questions
Stylus Medicine's website is https://www.stylusmedicine.com/
Stylus Medicine's LinkedIn profile is https://www.linkedin.com/company/stylus-medicine
Stylus Medicine has
39 employees.
View email and phone details for 39
employees at Stylus Medicine.
Stylus Medicine's industry is
Biotechnology Research
Stylus Medicine's top competitors are
Manifold Bio,
Scismic,
Stellaromics Inc.,
Pledge Therapeutics,
Nona Biosciences,
Qld Biotherapeutics Inc,
Marengo Therapeutics,
Oddity Labs,
Incendia Therapeutics,
Volta Labs, Inc..
Stylus Medicine's categories are Biotechnology Research
